Treatment Planning Systems And Advanced Image Processing Market Projected to Discern Stable Expansion by 2028

 Treatment Planning Systems And Advanced Image Processing Market Growth & Trends

The global treatment planning systems and advanced image processing market size is expected to reach USD 3.0 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 7.8% from 2021 to 2028. The increasing prevalence of cancer and rising product development pertaining to cancer research undertaken by key players are driving the market growth. According to estimates published by GLOBOCAN in 2020, 19.3 million new cancer cases were diagnosed and 10.0million cancer-related mortalities recorded.

As per the WHO, cancer is the leading cause of death globally and claims one in every six lives. According to Novartis, there are more than 200 types of cancers prevalent in the world and each requires a unique diagnosis and line of treatment. The growing cancer burden is expected to boost the demand for advanced oncology therapies with accurate and efficient results, thereby aiding the market growth.

Moreover, the oncology space is witnessing innovations and investments by market leaders to develop novel technologies that possess the potential to alter the treatment regime drastically. Advancements in healthcare infrastructure and the unraveling of opportunities in emerging markets are contributing to growth. Governments around the world are promoting public-private collaboration to accelerate product development.

Recent developments in the field of imaging technology have found wide-scale adoption in treatment planning, treatment simulation, and image guidance in radiotherapy processes. For instance, in January 2021, OncoLens raised USD 7.3 million in a Series A funding round. Additionally, General Atlantic invested around USD 200.0 million for launching OneOncology, a company designed for helping community oncology practices with technical data, innovation, and research. Furthermore, Purdue Pharma L.P is investing in its oncology R&D to diversify scientific research in high unmet medical need areas and thereby establishing a potential portfolio of delivering new cancer therapies to patients over the forthcoming years.

Furthermore, Artificial Intelligence (AI) and Machine Learning (ML) are witnessing increased adoption in oncology software systems to improve diagnosis, treatment plan, simulation, and management. The amalgamation of AI/ML has significantly improved diagnosis and imaging segments of oncology care. One such highlight of these deep learning algorithms was detecting skin cancer based on skin photographs.

AI used in cancer screening and detection further aids in treatment planning processes and prevents collateral tissue/organ damage. For instance, the American College of Radiology founded the Data Science Institute to promote collaboration amongst radiologists, private and public agencies to adopt and develop Ai-based imaging solutions. Similarly, the American Society of Clinical Oncology and American Society for Radiation Oncology initiated CancerLinQ and the National Institute of Health founded Big Data to Knowledge initiative. Additionally, the increase in investments in AI for oncology is contributing to market development and growth.

Request a free sample copy or view report summary: Treatment Planning Systems And Advanced Image Processing Market Report

Treatment Planning Systems And Advanced Image Processing Market Report Highlights

• The market is anticipated to witness significant growth over the forecast period owing to the increasing prevalence of cancer and rising investments in oncology
• Treatment planning software dominated the treatment planning systems and advanced image processing component segment in 2020, owing to increased demand for accurate and precise treatment options
• Validation of image registration application dominated the market in 2020 owing to an increasing need of forming real-time image datasets from multi-modalities and anatomical atlases
• North America dominated the market in 2020 owing to the presence of sophisticated healthcare infrastructure and cancer research institutes coupled with high healthcare expenditures

Access Press Release@ https://www.grandviewresearch.com/press-release/global-treatment-planning-system-advanced-image-processing-market

Treatment Planning Systems And Advanced Image Processing Market Segmentation

Grand View Research has segmented the global treatment planning system and advanced image processing market on the basis of component, application, technique, and region:

Treatment Planning System & Advanced Image Processing Component Outlook (Revenue, USD Million, 2016 - 2028)

• Advanced Image Processing Software
• Treatment Planning Software
  • Auto-Contouring Software
  • Multi-Modality Software
  • PET/CT Deformable Software
  • DICOM-RT Software

Treatment Planning System & Advanced Image Processing Technique Outlook (Revenue, USD Million, 2016 - 2028)

• 3D Image Reconstruction
• In-Room Imaging
• Image Registration using Graphics Processor Unit

Treatment Planning System & Advanced Image Processing Application Outlook (Revenue, USD Million, 2016 - 2028)

• Adaptive Radiotherapy
• Online Monitoring
• Tracking
• Dose Accumulation
• Validation of Image Registration

Treatment Planning System & Advanced Image Processing Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • Spain
  • France
  • Italy
  • Russia
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • Saudi Arabia
  • UAE
  • South Africa

List of Key Players of Treatment Planning Systems And Advanced Image Processing Market

• Accuray Incorporated
• Elekta
• Koninklijke PHILIPS N.V.
• RaySearch Laboratories
• Varian Medical Systems
• Brainlab
• Prowess Inc.
• DOSIsoft SA
• ViewRay Inc.
• MIM Software Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.